⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CYTK News
Cytokinetics Inc.
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CYTK
Bronstein, Gewirtz & Grossman, LLC Encourages Cytokinetics, Incorporated (CYTK) Stockholders to Inquire about Securities Investigation
accessnewswire.com
CYTK
Bronstein, Gewirtz & Grossman, LLC Encourages Cytokinetics, Incorporated (CYTK) Investors to Inquire about Securities Investigation
accessnewswire.com
CYTK
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cytokinetics, Incorporated (CYTK) And Encourages Investors to Reach Out
accessnewswire.com
CYTK
Bayer Accelerates Pharma Growth on High-Value Portfolio
businesswire.com
CYTK
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cytokinetics, Incorporated (CYTK) And Encourages Stockholders to Reach Out
accessnewswire.com
CYTK
Orsini Selected as Specialty Pharmacy Partner for Cytokinetics's MYQORZO™ (aficamten)
prnewswire.com
CYTK
CareMed Has Been Selected as a National Specialty Pharmacy Provider for MYQORZO™ (aficamten)
globenewswire.com
CYTK
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cytokinetics, Incorporated (CYTK) And Encourages Stockholders to Connect
accessnewswire.com
CYTK
Cytokinetics, Incorporated (CYTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
CYTK